Director · Edgewise Therapeutics, Inc. · Edgewise Therapeutics, Inc. — Stock Options (Right to buy)
Side
A
Value
—
Shares
45.1K
Price
—
Executed
Nov 19, 2025
Disclosed
Nov 24, 2025
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Nov 19 executedNov 24, 2025 disclosed
EWTX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Edgewise Therapeutics, Inc. — Stock Options (Right to buy)
Ticker
EWTX
Shares
45.1K
Price per share
$0
Execution date (reported)
Nov 19, 2025
Owned after transaction
45.1K shares
Days from execution to publication
5
What this establishes
Martin Christopher Nathan filed this Form 4 reporting a grant or award of EWTX on Nov 19, 2025. It became public on Nov 24, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Martin Christopher Nathancik:0002097992
Issuer
Edgewise Therapeutics, Inc.cik:0001710072
Revision history · 0
No field has changed since this record was first ingested.
